Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 1:22 AM
NCT ID:
NCT03227393
Eligibility Criteria:
Inclusion Criteria:
* Negative pregnancy test in females
* Ejection Fraction \</= 40% assessed by echocardiogram within the last 12 months
* Stable dose of heart failure medications including afterload reducing medication such as ACE-I, ARB and hydralazine; beta blockers; digoxin and aldosterone antagonist for at least 4 months and no anticipated changes for 8 weeks. (i.e. no greater than a 50% dose change within the past month)
* Has an implantable pacemaker or ICD
* NYHA II-IV
Exclusion Criteria:
* pregnant or lactating female
* females without a pregnancy test
* co-administration of a positive inotrope (i.e. milrinone or dobutamine)
* history of significant medical non-compliance
* unwilling to adhere to the protocol
* Orthopedic limitation making yoga participation difficult
* Underlying cardiac rhythm other than sinus rhythm
* Recent history within 6 months prior to enrollment of unstable coronary artery disease (unstable angina, recent heart attack, recent revascularization, or decompensated heart failure)
* implantation of a cardiac resynchronization therapy device in the past 3 months.
* TIA, CVA, or major surgery in the past 3 months
* iodine or adreview (123-MIBG) allergy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03227393
Study Brief:
Protocol Section:
NCT03227393